메뉴 건너뛰기




Volumn 36, Issue 10, 2012, Pages 992-993

Letter: Renal tubular dysfunction during nucleotide analogue therapy in chronic hepatitis B

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALKALINE PHOSPHATASE; CREATININE; TENOFOVIR;

EID: 84867530341     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12065     Document Type: Letter
Times cited : (2)

References (6)
  • 1
    • 84860519158 scopus 로고    scopus 로고
    • Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B
    • Gara N, Zhao X, Collins MT, et al,. Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. Aliment Pharmacol Ther 2012; 35: 1317-25.
    • (2012) Aliment Pharmacol Ther , vol.35 , pp. 1317-1325
    • Gara, N.1    Zhao, X.2    Collins, M.T.3
  • 2
    • 80053938419 scopus 로고    scopus 로고
    • Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients
    • Manolakopoulos S, Striki A, Deutch M, et al,. Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients. Liver Int 2011; 31: 1525-32.
    • (2011) Liver Int , vol.31 , pp. 1525-1532
    • Manolakopoulos, S.1    Striki, A.2    Deutch, M.3
  • 3
    • 70349230970 scopus 로고    scopus 로고
    • Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil
    • Ha NB, Ha NB, Garcia RT, et al,. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. Hepatology 2009; 50: 727-34.
    • (2009) Hepatology , vol.50 , pp. 727-734
    • Ha, N.B.1    Ha, N.B.2    Garcia, R.T.3
  • 4
    • 84555210080 scopus 로고    scopus 로고
    • Five years of treatment with tenofovir DF (TDF) for chronic hepatitis B (CHB) infection is associated with sustained viral suppression and significant regression of histological fibrosis and cirrhosis
    • Marcellin P, Buti M, Gane EJ, et al,. Five years of treatment with tenofovir DF (TDF) for chronic hepatitis B (CHB) infection is associated with sustained viral suppression and significant regression of histological fibrosis and cirrhosis. Hepatology 2011; 54 (Suppl.): 1011A-2A.
    • (2011) Hepatology , vol.54 , Issue.SUPPL.
    • Marcellin, P.1    Buti, M.2    Gane, E.J.3
  • 5
    • 84875671728 scopus 로고    scopus 로고
    • Tenofovir monotherapy for naive patients with chronic hepatitis B: A multicenter European study in clinical practice in 302 patients followed for 30 months
    • Lampertico P, Soffredini R, Vigaro M, et al,. Tenofovir monotherapy for naive patients with chronic hepatitis B: a multicenter European study in clinical practice in 302 patients followed for 30 months. J Hepatol 2012; 56 (Suppl. 2): S208.
    • (2012) J Hepatol , vol.56 , Issue.SUPPL. 2
    • Lampertico, P.1    Soffredini, R.2    Vigaro, M.3
  • 6
    • 84862664371 scopus 로고    scopus 로고
    • EASL Clinical practice guidelines: Management of chronic hepatitis B virus infection
    • European Association for the Study of the Liver
    • European Association for the Study of the Liver. EASL Clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-85.
    • (2012) J Hepatol , vol.57 , pp. 167-185


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.